STOCK TITAN

Veeva Systems Inc. - VEEV STOCK NEWS

Welcome to our dedicated page for Veeva Systems news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems stock.

Veeva Systems Inc. (NYSE: VEEV) is a global leader in cloud-based software solutions specifically tailored for the life sciences industry. Headquartered in the San Francisco Bay Area, Veeva Systems provides innovative technology that helps pharmaceutical and biotech companies streamline their operations, ensure compliance, and bring products to market faster. Veeva's product offerings address key operational and regulatory needs, ranging from customer relationship management (CRM) to content management and data analytics.

Two of the company's flagship products include Veeva CRM and Veeva Vault. Veeva CRM is designed for companies with a salesforce, providing tools to manage customer interactions more efficiently. Meanwhile, Veeva Vault is a versatile content management platform that supports various functions such as clinical trials, regulatory submissions, and quality management within life sciences companies.

Veeva serves a diverse customer base, ranging from emerging biotechs to some of the world's largest pharmaceutical companies. Its commitment to product excellence, customer success, and continuous innovation is evident as Veeva frequently updates its offerings to meet the evolving needs of the industry. Recently, Veeva announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications to streamline clinical execution and improve regulatory management in its animal health business unit.

Another notable achievement for Veeva was the launch of the Veeva AI Partner Program, designed to help partners integrate Generative AI solutions seamlessly with Veeva Vault applications. This initiative highlights Veeva's ongoing efforts to leverage advanced technologies to enhance its product ecosystem. Furthermore, the introduction of Veeva Vault CRM Campaign Manager aims to simplify and speed up non-personal promotion to healthcare professionals, ensuring consistent and compliant marketing efforts.

Financially, Veeva Systems has shown strong performance with its fiscal year 2024 results reflecting robust growth. The company continues to invest in its innovation engine and strategic partnerships, setting the stage for sustained, profitable growth. Veeva's recent financial outlook for fiscal year 2025 and first quarter results for 2024 further underline its market leadership and operational excellence.

For more information about Veeva Systems, its products, and latest updates, visit www.veeva.com.

Rhea-AI Summary
Veeva Systems announces successful adoption of Vault CRM by early customers in the U.S. and Europe, with plans for migration of existing Veeva CRM customers. The company expresses gratitude to customers and product team for the achievement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
-
Rhea-AI Summary
Veeva Systems announces increased adoption of Vault EDC with eight of the top 20 biopharmas standardizing on it, enabling faster study builds and streamlined processes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
-
Rhea-AI Summary
Veeva Systems (VEEV) to present at Morgan Stanley Technology, Media & Telecom Conference on March 6, 2024. CFO Brent Bowman to speak at 9:30 a.m. Pacific Time. Webcast available on Veeva's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
conferences
Rhea-AI Summary
Veeva Systems Inc. reports Fiscal Year 2024 Total Revenues of $2,363.7M, up 10% Year Over Year, with Q4 Total Revenues of $630.6M, up 12% Year Over Year. The company achieved growth in Subscription Services Revenues and introduced new products like the Veeva Compass Suite and Clinical Platform. Despite a decrease in net income for Q4, Veeva remains optimistic about its future growth and impact on the life sciences industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
-
Rhea-AI Summary
Boehringer Ingelheim adopts Veeva Vault Clinical and Veeva Vault RIM for streamlined clinical and regulatory management in its animal health business unit, aiming to accelerate the development of new medicines for animals and improve operational efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
partnership
-
Rhea-AI Summary
Veeva Systems introduces Veeva Vault Submissions Publishing eLearning, a new regulatory information management application to educate users on key publishing processes. The on-demand training program aims to streamline development of compliant content, increase efficiency, and enhance employee qualification.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
none
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) will announce financial results for its fourth quarter and full fiscal year on February 29, 2024. The company will host a conference call and webcast to discuss its financial results. Prepared remarks will be posted to its investor relations website. Investors and analysts can register for the conference call and access the webcast replay on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) has announced the availability of the full Veeva Compass Suite of commercial data products, including Compass Prescriber and Compass National, providing projections for both retail prescriptions and complex procedures. The suite also includes Compass Patient, offering granular, longitudinal patient data. The products are licensed by the brand and give unlimited data access, including historical data. The availability of the full Veeva Compass Suite of data products is a significant milestone for the industry and Veeva, delivering innovations in commercial data for life sciences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) announced that over 350 companies are using its training solutions to modernize employee qualification processes, with a focus on GxP training. The solutions help prevent quality deficiencies, job-related errors, and audit failures, while also improving job performance and ensuring inspection readiness.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
none
Rhea-AI Summary
Veeva Systems (VEEV) announced that a top 20 biopharma and Veeva Services migrated 25 ongoing clinical studies to Veeva Vault EDC from a legacy electronic data capture application. This successful migration is an industry first and includes a large study with over 500 research sites and 7,000 patients. The customer plans to use Vault EDC for all current and future trials globally. The migration was enabled by Vault EDC's proprietary capability to migrate ongoing studies securely with minimal disruption, addressing concerns about technical challenges and complex data models. This capability allows customers to decommission legacy EDC systems while advancing clinical data management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.57%
Tags
none

FAQ

What is the current stock price of Veeva Systems (VEEV)?

The current stock price of Veeva Systems (VEEV) is $216.58 as of November 22, 2024.

What is the market cap of Veeva Systems (VEEV)?

The market cap of Veeva Systems (VEEV) is approximately 34.8B.

What does Veeva Systems Inc. do?

Veeva Systems Inc. provides cloud-based software solutions for the global life sciences industry, including tools for CRM, content management, and data analytics.

Where is Veeva Systems Inc. headquartered?

Veeva Systems Inc. is headquartered in the San Francisco Bay Area.

What are Veeva's main products?

Veeva's main products include Veeva CRM, a customer relationship management platform, and Veeva Vault, a content management platform.

Who are Veeva Systems' customers?

Veeva Systems serves over 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs.

What recent partnerships has Veeva announced?

Recently, Veeva announced a partnership with Boehringer Ingelheim, which selected Veeva Vault Clinical and Veeva Vault RIM for its animal health business unit.

What is the Veeva AI Partner Program?

The Veeva AI Partner Program provides partners with technology and support to integrate Generative AI solutions seamlessly with Veeva Vault applications.

How has Veeva performed financially recently?

Veeva has reported strong financial results for fiscal year 2024 and continues to show robust growth and operational excellence.

What is Veeva Vault CRM Campaign Manager?

Veeva Vault CRM Campaign Manager is a new marketing application that simplifies and speeds non-personal promotion to healthcare professionals, ensuring consistency and compliance.

What industry does Veeva Systems primarily serve?

Veeva Systems primarily serves the life sciences industry.

How does Veeva contribute to the life sciences industry?

Veeva helps life sciences companies streamline operations, ensure compliance, and bring products to market faster through its innovative cloud-based software solutions.

Veeva Systems Inc.

NYSE:VEEV

VEEV Rankings

VEEV Stock Data

34.82B
147.45M
8.94%
83.6%
1.48%
Health Information Services
Services-prepackaged Software
Link
United States of America
PLEASANTON